Crinetics Pharmaceuticals (CRNX)
(Delayed Data from NSDQ)
$53.15 USD
-0.09 (-0.17%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $53.14 -0.01 (-0.02%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-0.91 | -0.09% |
Earnings Summary
For their last quarter, Crinetics Pharmaceuticals (CRNX) reported earnings of -$0.94 per share, missing the Zacks Consensus Estimate of -$0.86 per share. This reflects a negative earnings surprise of 9.30%. Look out for CRNX's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.91 per share, reflecting a year-over-year increase of 9.9%.
Earnings History
Price & Consensus
Zacks News for CRNX
Aquestive Therapeutics (AQST) Reports Q2 Loss, Tops Revenue Estimates
CRNX: What are Zacks experts saying now?
Zacks Private Portfolio Services